$Moleculin Biotech (MBRX.US)$ 1)       Phase 3 clinical trial of annamycin for Acute myeloid leukemia (AML) is under way.  It was referred to as MIRACLE (Moleculin R/R AML AnnAraC Clinical Evaluation) Trial. This phase 3 clinical trial will be global, including sites in the US, Europe and the Middle East. It is well planned and will have the first interim read-out later this year, which is very efficient and exceptional.  
 
2)       Importantly...

$Moleculin Biotech (MBRX.US)$
Moleculin Announces Exercise of Warrants for $5.8 Million Gross Proceeds
Thursday, 13th February at 1:05 pm
HOUSTON, Feb. 13, 2025 /PRNewswire/ -- Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced it has entered into agreements with certain holders of its existing warrants for the immediate exercise of cer...

$Moleculin Biotech (MBRX.US)$ like that how to sell actually

$Moleculin Biotech (MBRX.US)$ how to play

$Snow Lake Resources (LITM.US)$
Snow Lake Accelerates Uranium Strategy with Successful Phase 1 Results and Upcoming Phase 2 Drill Program
Snow Lake Resources (NASDAQ: LITM)has announced successful completion of its Phase 1 drill program at the Engo Valley Uranium Project, revealing significant uranium mineralization. The program comprised 1,570 meters of drilling across 20 reverse circulation drill holes, with 11 holes showing mineralized intersections exceeding 100 ppm eU3O8.
The company pla...

$Snow Lake Resources (LITM.US)$ How much longer do we have to wait for the exploration results?

$Snow Lake Resources (LITM.US)$ Are you okay?